Syndax Pharmaceuticals Inc (NASDAQ:SNDX)

18.58
Delayed Data
As of Oct 15
 +0.09 / +0.49%
Today’s Change
13.02
Today|||52-Week Range
27.85
-16.46%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$903.5M

Company Description

Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.

Contact Information

Syndax Pharmaceuticals, Inc.
35 Gatehouse Drive
Waltham Massachusetts 02451
P:(781) 419-1400
Investor Relations:

Employees

Chart unavailable

Shareholders

Other institutional78.09%
Mutual fund holders22.36%
Individual stakeholders13.82%

Top Executives

Briggs W. MorrisonChief Executive Officer & Director
Michael A. MetzgerPresident, Chief Operating Officer & Director
Daphne KarydasChief Financial Officer
Peter OrdentlichChief Scientific Officer
Michael L. MeyersChief Medical Officer & Senior Vice President